Acidic DEGEE Topical Compositions Without Preservatives

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Topical pharmaceutical compositions require antimicrobial preservatives to prevent microbial proliferation, which are toxic and need to be kept at low concentrations, posing challenges in ensuring effective preservation without compromising patient safety.

Innovation Solution

Topical pharmaceutical compositions are formulated with diethylene glycol monoethyl ether (DEGEE) at an acidic pH, optionally with an emulsifier blend of cetearyl alcohol, dicetyl phosphate, and ceteth-10 phosphate, eliminating the need for traditional antimicrobial preservatives while maintaining preservation efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional antimicrobial preservatives are added to topical pharmaceutical compositions, then microbial proliferation is prevented, but patient safety is compromised due to toxicity

Engineering Contradiction:
Improvepreservation efficacyVSAvoidtoxicity to patient
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the pH parameter of the formulation to an acidic range (pH 3.0-6.0), which creates an environment that prevents microbial proliferation without requiring toxic preservatives. This parameter change transforms the preservation mechanism from chemical (preservative-based) to physical-chemical (pH-based), thereby maintaining reliability while reducing harmful effects to patients

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts and eliminates traditional antimicrobial preservatives from the formulation, replacing them with an acidic pH environment. This removal of harmful substances while maintaining preservation function directly resolves the contradiction between effective preservation and patient safety

Inventive Principle:
Principle #2Taking out (Extraction)

2Reliability

If antimicrobial preservatives are added to prevent microbial contamination, then preservation is effective, but the formulation complexity increases

Engineering Contradiction:
Improvepreservation effectivenessVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent removes traditional preservative components from the formulation, simplifying the ingredient list while maintaining preservation effectiveness through pH control. This extraction of unnecessary components directly reduces formulation complexity

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The acidic pH environment serves multiple functions simultaneously: it provides preservation against microbial contamination, maintains skin compatibility, and simplifies the overall formulation. This multi-functionality reduces the need for separate preservative systems, thereby reducing formulation complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compositions achieve effective antimicrobial preservation without traditional preservatives, meeting European Pharmacopeia and USP criteria, ensuring safety and efficacy over the product's shelf life.

Implementation Method 1

topical pharmaceutical compositions comprising diethylene glycol monoethyl ether (DEGEE) maintained at an acidic pH were fully preserved without the addition of a traditional antimicrobial preservative

Methodology Applied
Scientific EffectAcidic pH inhibition:

Data Source

PatentUS20260014099A1Self-preserving topical pharmaceutical compositions comprising diethylene glycol monoethyl ether
Publication Date: 2026.01.15 ARCUTIS BIOTHERAPEUTICS INC
  • US20260014099A1 patent drawing
  • US20260014099A1 patent drawing

AI summary

Topical pharmaceutical compositions comprising diethylene glycol monoethyl ether (DEGEE) maintained at an acidic pH. The pH of the formulation can be maintained at a pH of less than 6.3, or alternatively less than 6.0. Certain pharmaceutical composition further comprise an emulsifier blend of cetearyl alcohol, dicetyl phosphate, and ceteth-10 phosphate, which is manufactured by Croda under the tradename Crodafos™ CES.